[2]
Smith EM, Parker MA, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Evidence for vertical transmission of HPV from mothers to infants. Infect Dis Obstet Gynecol 2010; 2010: 326369.
[3]
Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 2011; 204(4): 566-73.
[4]
Cho G, Min KJ, Hong HR, et al. High-risk human papillomavirus infection is associated with premature rupture of membranes. BMC Pregnancy Childbirth 2013; 13: 173.
[5]
Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 1984; 6(6): 814-31.
[6]
McDonnold M, Dunn H, Hester A, et al. High risk human papillomavirus at entry to prenatal care and risk of preeclampsia. Am J Obstet Gynecol 2014; 210(2): 138.e1-5.
[7]
Niyibizi J, Zanré N, Mayrand M-H, Trottier H. The association between adverse pregnancy outcomes and maternal human papillomavirus infection: A systematic review protocol. Syst Rev 2017; 6(1): 53.
[9]
ACOG Committee on Obstetric Practice. ACOG Committee on Practice Bulletins--Obstetrics. ACOG Practice bulletin no.33: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002; 99(1): 159-67.
[10]
Qazi G. Obstetric and perinatal outcome of multiple pregnancy. J Coll Physicians Surg Pak 2011; 21(3): 142-5.
[11]
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371(9606): 75-84.
[12]
Liu P, Xu L, Sun Y, Wang Z. The prevalence and risk of human papillomavirus infection in pregnant women. Epidemiol Infect 2014; 142(8): 1567-78.
[13]
Waller J, Marlow LA, Wardle J. The association between knowledge of HPV and feelings of stigma, shame and anxiety. Sex Transm Infect 2007; 83(2): 155-9.
[14]
Johnson HL, Ghanem KG, Zenilman JM, Erbelding EJ. Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics. Sex Transm Dis 2011; 38(3): 167-71.
[15]
Waight MT, Rahman MM, Soto P, Tran T. Sexually transmitted diseases during pregnancy in Louisiana, 2007-2009: high-risk populations and adverse newborn outcomes. J La State Med Soc 2013; 165(4): 219-26.
[16]
Valero de Bernabé J, Soriano T, Albaladejo R, et al. Risk factors for low birth weight: a review. Eur J Obstet Gynecol Reprod Biol 2004; 116(1): 3-15.
[17]
Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB, Parry S. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod 2008; 23(3): 709-15.
[18]
Salafia CM, Pezzullo JC, Ghidini A, Lopez-Zeno JA, Whittington SS. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta 1998; 19(1): 67-72.
[19]
da Silva Cardeal LB, Brohem CA, Correa TC, et al. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol 2006; 84(5): 713-9.
[20]
Ota A, Yonemoto H, Someya A, Itoh S, Kinoshita K, Nagaoka I. Changes in matrix metalloproteinase 2 activities in amniochorions during premature rupture of membranes. J Soc Gynecol Investig 2006; 13(8): 592-7.
[21]
Kato Y, Yamashita T, Ishikawa M. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep 2002; 9(3): 565-9.
[22]
Kaur H, Schmidt-Grimminger D, Remmenga SW, Chen B, Islam KMM. Does Human papillomavirus affect pregnancy outcomes? An analysis of hospital data 2012-2014. Int J Womens Health Wellness 2015; 1(006): 2.
[23]
Heumann CL, Quilter LA, Eastment MC, Heffron R, Hawes SE. Adverse birth outcomes and maternal Neisseria gonorrhoeae infection: A population-based cohort study in Washington State. Sex Transm Dis 2017; 44(5): 266-71.
[24]
Liu B, Roberts CL, Clarke M, Jorm L, Hunt J, Ward J. Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: A retrospective cohort study. Sex Transm Infect 2013; 89(8): 672-8.
[25]
Shew ML, Ermel AC, Weaver BA, et al. Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance. J Infect Dis 2013; 208(9): 1416-21.
[26]
Samoff E, Koumans EH, Markowitz LE, et al. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005; 162(7): 668-75.
[27]
Shulman HB, Gilbert BC, Msphbrenda CG, Lansky A. The Pregnancy Risk Assessment Monitoring System (PRAMS): Current methods and evaluation of 2001 response rates. Public Health Rep 2006; 121(1): 74-83.
31
4